Translating Micro/Nano Engineering Innovations into Clinic

Our lab focuses on the development of new technologies for molecular analysis and biomedical research via advances in micro- and nano-scale sciences. We aim to develop new methods, devices and systems with unprecedented performance characteristics, such as sensitivity, specificity, resolution (temporal and/or spatial), multiplexing and throughput to rectify current technological limitations in the molecular study of diseases. By forging long-term collaborations with medical scientists and physicians across various disciplines (e.g. Oncology, Pathology, Surgery and Emergency Medicine) and by leveraging our engineering innovations in microfluidics, single molecule spectroscopy and functional nanoparticles, we are developing genetic and epigenetic biomarker-based diagnostics , prognostics and monitoring for cancer and an array of other diseases.

Latest   News:

04/2012 Yin and Yang in a Droplet. Yi Zhang’s award winning image was featured on the front cover of Lab Chip. The fluorescence image is described as a snapshot of the mixing of two types of quantum dot solutions inside a sessile droplet driven by a microfluidic magnetic gyromixer. The mixing results in quantum dot streamlines that resemble the ancient Chinese symbol for Yin and Yang.
03/2012 The Lindau Nobel Laureate Meetings. Helena Zec has been selected to attend the 62nd Lindau Nobel Laureate Meeting to be held 1-6 July 2012 in in Germany.
03/2012 BioMEMS Lab alumnus Tim Yeh accepting the Assistant Professor position in the Biomedical Engineering Department at UT Austin.
02/2012 ACS Nano Podcast featuring an interview with Dr. Jeff Wang about quantum nanotethers for high-resolution genetic analysis.
02/2012 BioMEMS Lab alumnus Megan Ho receives Sapere Aude Young Elite Researcher Award and will join iNANO at Aarhus University in Denmark.
10/2011 μTAS Art in Science Award. Yi Zhang and Dong Jin Shin (center) receives the 4th annual μTAS Art in Science Award, presented by Michael Gaitan of NIST (left) and Harpal Minhas of LOC/RSC (right).
07/2011 Dr. Wang received a R01 grant of $1.7M from NIH/NCI for the development of multiplexed single-molecule detection platform for analysis of cancer biomarkers.